JP2015518463A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015518463A5 JP2015518463A5 JP2014561310A JP2014561310A JP2015518463A5 JP 2015518463 A5 JP2015518463 A5 JP 2015518463A5 JP 2014561310 A JP2014561310 A JP 2014561310A JP 2014561310 A JP2014561310 A JP 2014561310A JP 2015518463 A5 JP2015518463 A5 JP 2015518463A5
- Authority
- JP
- Japan
- Prior art keywords
- unsaturated
- saturated
- bond
- independently
- linear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12001803.1 | 2012-03-16 | ||
| EP12001803 | 2012-03-16 | ||
| PCT/EP2013/000698 WO2013135359A1 (en) | 2012-03-16 | 2013-03-11 | Targeting aminoacid lipids |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018102256A Division JP2018141015A (ja) | 2012-03-16 | 2018-05-29 | 標的指向アミノ酸脂質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015518463A JP2015518463A (ja) | 2015-07-02 |
| JP2015518463A5 true JP2015518463A5 (enExample) | 2016-04-28 |
| JP6527331B2 JP6527331B2 (ja) | 2019-06-05 |
Family
ID=47901004
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014561310A Active JP6527331B2 (ja) | 2012-03-16 | 2013-03-11 | 標的指向アミノ酸脂質 |
| JP2018102256A Pending JP2018141015A (ja) | 2012-03-16 | 2018-05-29 | 標的指向アミノ酸脂質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018102256A Pending JP2018141015A (ja) | 2012-03-16 | 2018-05-29 | 標的指向アミノ酸脂質 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9878044B2 (enExample) |
| EP (1) | EP2825156B1 (enExample) |
| JP (2) | JP6527331B2 (enExample) |
| KR (2) | KR102208586B1 (enExample) |
| CN (1) | CN104168888A (enExample) |
| AU (2) | AU2013231638B2 (enExample) |
| BR (1) | BR112014022451B1 (enExample) |
| CA (1) | CA2867169C (enExample) |
| DK (1) | DK2825156T3 (enExample) |
| ES (1) | ES2644778T3 (enExample) |
| HK (1) | HK1198924A1 (enExample) |
| IL (1) | IL234550A (enExample) |
| MX (1) | MX354811B (enExample) |
| NO (1) | NO2825156T3 (enExample) |
| NZ (1) | NZ631034A (enExample) |
| PT (1) | PT2825156T (enExample) |
| RU (1) | RU2654210C2 (enExample) |
| SG (2) | SG10201610401XA (enExample) |
| TW (1) | TWI586370B (enExample) |
| WO (1) | WO2013135359A1 (enExample) |
| ZA (1) | ZA201407490B (enExample) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8067237B2 (en) | 2005-12-13 | 2011-11-29 | President And Fellows Of Harvard College | Scaffolds for cell transplantation |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| SI3590949T1 (sl) | 2010-10-01 | 2022-09-30 | Modernatx, Inc. | Ribonukleinske kisline, ki vsebujejo N1-metil-psevdouracil, in njihove uporabe |
| CA2813751C (en) | 2010-10-06 | 2019-11-12 | President And Fellows Of Harvard College | Injectable, pore-forming hydrogels for materials-based cell therapies |
| JP2014511687A (ja) | 2011-03-31 | 2014-05-19 | モデルナ セラピューティクス インコーポレイテッド | 工学操作された核酸の送達および製剤 |
| US9675561B2 (en) | 2011-04-28 | 2017-06-13 | President And Fellows Of Harvard College | Injectable cryogel vaccine devices and methods of use thereof |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2763701B1 (en) | 2011-10-03 | 2018-12-19 | Moderna Therapeutics, Inc. | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| RU2649364C2 (ru) | 2011-12-16 | 2018-04-02 | Модерна Терапьютикс, Инк. | Составы на основе модифицированного нуклеозида, нуклеотида и нуклеиновой кислоты |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US9878056B2 (en) | 2012-04-02 | 2018-01-30 | Modernatx, Inc. | Modified polynucleotides for the production of cosmetic proteins and peptides |
| EP3520821A1 (en) | 2012-04-02 | 2019-08-07 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of biologics and proteins associated with human disease |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| CN107137357B (zh) | 2012-04-16 | 2020-11-24 | 哈佛学院董事会 | 用于调节免疫反应的介孔二氧化硅组合物 |
| SI2922554T1 (sl) | 2012-11-26 | 2022-06-30 | Modernatx, Inc. | Terminalno modificirana RNA |
| US10258698B2 (en) | 2013-03-14 | 2019-04-16 | Modernatx, Inc. | Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| BR112015032713B1 (pt) | 2013-09-17 | 2023-03-21 | Obi Pharma, Inc | Composto, composição farmacêutica, uso de uma quantidade terapeuticamente efetiva da composição farmacêutica, e uso do composto |
| US10023626B2 (en) | 2013-09-30 | 2018-07-17 | Modernatx, Inc. | Polynucleotides encoding immune modulating polypeptides |
| KR20160067219A (ko) | 2013-10-03 | 2016-06-13 | 모더나 세라퓨틱스, 인코포레이티드 | 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드 |
| MA58292B1 (fr) | 2014-04-23 | 2025-01-31 | Modernatx, Inc. | Vaccins à base d'acide nucléique |
| US10682400B2 (en) | 2014-04-30 | 2020-06-16 | President And Fellows Of Harvard College | Combination vaccine devices and methods of killing cancer cells |
| WO2016123573A1 (en) | 2015-01-30 | 2016-08-04 | President And Fellows Of Harvard College | Peritumoral and intratumoral materials for cancer therapy |
| EP3280464A4 (en) | 2015-04-10 | 2018-09-26 | President and Fellows of Harvard College | Immune cell trapping devices and methods for making and using the same |
| JP2018532990A (ja) * | 2015-09-04 | 2018-11-08 | オービーアイ ファーマ，インコーポレイテッド | グリカンアレイおよび使用の方法 |
| JP6948313B6 (ja) | 2015-09-17 | 2022-01-14 | モデルナティエックス インコーポレイテッド | 治療剤の細胞内送達のための化合物および組成物 |
| CN105505382B (zh) * | 2015-12-04 | 2017-06-27 | 安徽师范大学 | 一种铜纳米簇溶液的制备方法及应用 |
| SMT202200358T1 (it) | 2015-12-10 | 2022-11-18 | Modernatx Inc | Composizioni e metodi di rilascio degli agenti terapeutici |
| EP3394030B2 (en) | 2015-12-22 | 2025-02-12 | ModernaTX, Inc. | Compounds and compositions for intracellular delivery of agents |
| CN115487351A (zh) | 2016-02-06 | 2022-12-20 | 哈佛学院校长同事会 | 重塑造血巢以重建免疫 |
| KR20180121786A (ko) | 2016-03-29 | 2018-11-08 | 오비아이 파머 인코퍼레이티드 | 항체, 제약 조성물 및 방법 |
| US10980894B2 (en) | 2016-03-29 | 2021-04-20 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| KR20250048399A (ko) | 2016-04-22 | 2025-04-08 | 오비아이 파머 인코퍼레이티드 | 글로보 계열 항원을 통한 면역 활성화 또는 면역 조정에 의한 암 면역요법 |
| KR102533456B1 (ko) | 2016-05-18 | 2023-05-17 | 모더나티엑스, 인크. | 릴랙신을 인코딩하는 폴리뉴클레오타이드 |
| DK3484448T3 (da) * | 2016-07-13 | 2025-06-10 | Harvard College | Antigenpræsenterende cellemimetiske stilladser og fremgangsmåder til fremstilling og brug af disse |
| US11642400B2 (en) | 2016-07-27 | 2023-05-09 | Obi Pharma, Inc. | Immunogenic/therapeutic glycan compositions and uses thereof |
| JP7121724B2 (ja) | 2016-07-29 | 2022-08-18 | オービーアイ ファーマ，インコーポレイテッド | ヒト抗体、医薬組成物及び方法 |
| JP7274214B2 (ja) | 2016-08-02 | 2023-05-16 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 免疫応答を調節するための生体材料 |
| CN110312799A (zh) * | 2016-08-17 | 2019-10-08 | 博德研究所 | 新型crispr酶和系统 |
| CN110114461A (zh) | 2016-08-17 | 2019-08-09 | 博德研究所 | 新型crispr酶和系统 |
| WO2018038549A1 (ko) * | 2016-08-24 | 2018-03-01 | 울산대학교 산학협력단 | Dtbp를 이용한 미생물 농축 또는 핵산 추출 방법 |
| KR102026683B1 (ko) | 2016-08-24 | 2019-09-30 | 울산대학교 산학협력단 | Dtbp를 이용한 미생물 농축 또는 핵산 추출 방법 |
| EP3538067A1 (en) | 2016-11-08 | 2019-09-18 | Modernatx, Inc. | Stabilized formulations of lipid nanoparticles |
| CA3044274A1 (en) | 2016-11-21 | 2018-05-24 | Obi Pharma, Inc. | Conjugated biological molecules, pharmaceutical compositions and methods |
| DE17829597T1 (de) * | 2016-11-30 | 2019-12-05 | Noxxon Pharma Ag | Verfahren zur polyalkoxylierung von nukleinsäuren zur rückgewinnung und wiederverwendung einer überschüssigen polyalkoxylierungsreagenz |
| SI3596042T1 (sl) | 2017-03-15 | 2022-04-29 | Modernatx, Inc. | Kristalne oblike amino lipidov |
| WO2018170336A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Lipid nanoparticle formulation |
| DK3596041T3 (da) | 2017-03-15 | 2023-01-23 | Modernatx Inc | Forbindelse og sammensætninger til intracellulær afgivelse af terapeutiske midler |
| EP3638678B1 (en) | 2017-06-14 | 2025-12-03 | ModernaTX, Inc. | Compounds and compositions for intracellular delivery of agents |
| MA49421A (fr) | 2017-06-15 | 2020-04-22 | Modernatx Inc | Formulations d'arn |
| CA3073211A1 (en) | 2017-08-31 | 2019-03-07 | Modernatx, Inc. | Methods of making lipid nanoparticles |
| EP3706713A4 (en) * | 2017-11-09 | 2021-06-16 | ImmunoVaccine Technologies Inc. | PHARMACEUTICAL COMPOSITIONS, METHOD OF MANUFACTURING THEREOF, INCLUDING SIZING OF LIPID VESICLE PARTICLES, AND USES |
| US11203645B2 (en) | 2018-06-27 | 2021-12-21 | Obi Pharma, Inc. | Glycosynthase variants for glycoprotein engineering and methods of use |
| WO2020061129A1 (en) | 2018-09-19 | 2020-03-26 | President And Fellows Of Harvard College | Compositions and methods for labeling and modulation of cells in vitro and in vivo |
| US12263248B2 (en) | 2018-09-19 | 2025-04-01 | Modernatx, Inc. | Compounds and compositions for intracellular delivery of therapeutic agents |
| JP7640452B2 (ja) | 2018-09-19 | 2025-03-05 | モデルナティエックス インコーポレイテッド | 高純度ｐｅｇ脂質及びそれらの使用 |
| WO2020061284A1 (en) | 2018-09-19 | 2020-03-26 | Modernatx, Inc. | Peg lipids and uses thereof |
| US12090235B2 (en) | 2018-09-20 | 2024-09-17 | Modernatx, Inc. | Preparation of lipid nanoparticles and methods of administration thereof |
| EP3938784A1 (en) | 2019-03-13 | 2022-01-19 | Merck Patent GmbH | Process for the preparation of lipidated proteinaceous structures |
| KR20220101077A (ko) | 2019-09-19 | 2022-07-19 | 모더나티엑스, 인크. | 치료제의 세포내 전달을 위한 분지형 꼬리 지질 화합물 및 조성물 |
| MX2022010980A (es) * | 2020-03-04 | 2022-12-02 | Verve Therapeutics Inc | Composiciones y metodos para el suministro de arn dirigido. |
| US11524023B2 (en) | 2021-02-19 | 2022-12-13 | Modernatx, Inc. | Lipid nanoparticle compositions and methods of formulating the same |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55500053A (enExample) | 1978-01-16 | 1980-01-31 | ||
| US4144034A (en) * | 1978-03-27 | 1979-03-13 | Texaco Inc. | Polyether-maleic anhydride reaction product containing motor fuel composition |
| ATE31560T1 (de) | 1983-11-10 | 1988-01-15 | Hoesch Ag | Verfahren und vorrichtung zum elektrolytischen abscheiden von metallen. |
| US5512439A (en) | 1988-11-21 | 1996-04-30 | Dynal As | Oligonucleotide-linked magnetic particles and uses thereof |
| US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| US6030954A (en) | 1991-09-05 | 2000-02-29 | University Of Connecticut | Targeted delivery of poly- or oligonucleotides to cells |
| US6335434B1 (en) | 1998-06-16 | 2002-01-01 | Isis Pharmaceuticals, Inc., | Nucleosidic and non-nucleosidic folate conjugates |
| IT1254135B (it) | 1992-01-16 | 1995-09-08 | Sigma Tau Ind Farmaceuti | Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antibatterica. |
| US6214388B1 (en) | 1994-11-09 | 2001-04-10 | The Regents Of The University Of California | Immunoliposomes that optimize internalization into target cells |
| US6056973A (en) | 1996-10-11 | 2000-05-02 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method of preparation |
| IL132941A0 (en) | 1997-05-21 | 2001-03-19 | Univ Leland Stanford Junior | Composition and method for enhancing transport across biological membranes |
| AU783647B2 (en) * | 1999-04-20 | 2005-11-17 | University Of British Columbia, The | Cationic peg-lipids and methods of use |
| AU7404800A (en) | 1999-09-30 | 2001-04-30 | Novo Nordisk A/S | A method for preparing conjugates between an antigen and mucosal binding component |
| JP4678967B2 (ja) * | 2001-03-08 | 2011-04-27 | 本田技研工業株式会社 | ゲル化性有機化合物及びそれを用いるゲル |
| GB0106041D0 (en) * | 2001-03-12 | 2001-05-02 | Cancer Res Ventures Ltd | Lipids and liposomes |
| EP3231445A1 (en) | 2001-05-18 | 2017-10-18 | Sirna Therapeutics, Inc. | Conjugates and compositions for cellular delivery |
| JP5093547B2 (ja) * | 2001-08-24 | 2012-12-12 | 日本ケミカルリサーチ株式会社 | 両イオン性脂質およびその用途 |
| WO2003022910A1 (en) | 2001-09-08 | 2003-03-20 | Access Pharmaceuticals, Inc. | Synthesis and uses of polymer gel nanoparticle networks |
| EP1308167A1 (de) | 2001-11-06 | 2003-05-07 | Pickl, Winfried, Ao. Univ. Prof. Dr. | Antigenpräsentierende Vesikel |
| JP4331927B2 (ja) * | 2002-08-29 | 2009-09-16 | 協立化学産業株式会社 | 無機ナノ粒子−有機化合物複合体およびそれの一次元配列集積構造体 |
| CA2536357A1 (en) * | 2003-05-29 | 2004-12-23 | The Scripps Research Institute | Targeted delivery to legumain-expressing cells |
| ATE493152T1 (de) | 2004-09-23 | 2011-01-15 | Guerbet Sa | Liposomale kontrastmittel für die cest-bildgebung |
| US20100028450A1 (en) | 2006-01-25 | 2010-02-04 | The Board Of Trustees Of The University Of Illinoi S | Tolerogenic biodegradable artificial antigen presenting system |
| WO2009129387A2 (en) * | 2008-04-16 | 2009-10-22 | Abbott Laboratories | Cationic lipids and uses thereof |
| US20090285881A1 (en) * | 2008-04-16 | 2009-11-19 | Abbott Laboratories | Cationic lipids and uses thereof |
| US20100104629A1 (en) | 2008-04-16 | 2010-04-29 | Abbott Laboratories | Cationic lipids and uses thereof |
| RU2409587C2 (ru) * | 2009-03-04 | 2011-01-20 | Государственное образовательное учреждение высшего профессионального образования "Московская государственная академия тонкой химической технологии имени М.В. Ломоносова" | 1-гексадецил-5-(1-пиренбутил)-n-(l-орнитил)-l-глутамат бисхлорид |
| WO2012031175A2 (en) | 2010-09-02 | 2012-03-08 | The Scripps Research Institute | Nanoparticle-based tumor-targeted drug delivery |
| WO2012148891A1 (en) * | 2011-04-29 | 2012-11-01 | Evonik Degussa Corporation | Peptide-lipid conjugates and uses thereof |
| SG10201610402VA (en) * | 2012-03-16 | 2017-02-27 | Merck Patent Gmbh | Aminoacid lipids |
-
2013
- 2013-03-11 JP JP2014561310A patent/JP6527331B2/ja active Active
- 2013-03-11 AU AU2013231638A patent/AU2013231638B2/en active Active
- 2013-03-11 US US14/384,702 patent/US9878044B2/en active Active
- 2013-03-11 SG SG10201610401XA patent/SG10201610401XA/en unknown
- 2013-03-11 RU RU2014141545A patent/RU2654210C2/ru active
- 2013-03-11 KR KR1020147028906A patent/KR102208586B1/ko active Active
- 2013-03-11 NZ NZ631034A patent/NZ631034A/en unknown
- 2013-03-11 SG SG11201405552VA patent/SG11201405552VA/en unknown
- 2013-03-11 BR BR112014022451-0A patent/BR112014022451B1/pt active IP Right Grant
- 2013-03-11 MX MX2014010808A patent/MX354811B/es active IP Right Grant
- 2013-03-11 KR KR1020207008113A patent/KR20200036033A/ko not_active Ceased
- 2013-03-11 HK HK14112479.9A patent/HK1198924A1/xx unknown
- 2013-03-11 CA CA2867169A patent/CA2867169C/en active Active
- 2013-03-11 PT PT137102935T patent/PT2825156T/pt unknown
- 2013-03-11 NO NO13710293A patent/NO2825156T3/no unknown
- 2013-03-11 WO PCT/EP2013/000698 patent/WO2013135359A1/en not_active Ceased
- 2013-03-11 EP EP13710293.5A patent/EP2825156B1/en active Active
- 2013-03-11 ES ES13710293.5T patent/ES2644778T3/es active Active
- 2013-03-11 DK DK13710293.5T patent/DK2825156T3/en active
- 2013-03-11 CN CN201380013774.1A patent/CN104168888A/zh active Pending
- 2013-03-15 TW TW102109381A patent/TWI586370B/zh active
-
2014
- 2014-09-09 IL IL234550A patent/IL234550A/en active IP Right Grant
- 2014-10-15 ZA ZA2014/07490A patent/ZA201407490B/en unknown
-
2018
- 2018-01-11 US US15/867,985 patent/US11510988B2/en active Active
- 2018-01-12 AU AU2018200293A patent/AU2018200293B2/en active Active
- 2018-05-29 JP JP2018102256A patent/JP2018141015A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015518463A5 (enExample) | ||
| JP2016525888A5 (enExample) | ||
| JP2015522045A5 (enExample) | ||
| JP2016520672A5 (enExample) | ||
| JP2014526140A5 (enExample) | ||
| JP2013500200A5 (enExample) | ||
| JP2016532680A5 (enExample) | ||
| JP2015518492A5 (enExample) | ||
| JP2011037885A5 (enExample) | ||
| JP2015537124A5 (enExample) | ||
| JP2012250569A5 (enExample) | ||
| JP2014508179A5 (enExample) | ||
| JP2017115098A5 (enExample) | ||
| JP2017181387A5 (enExample) | ||
| JP2015078187A5 (enExample) | ||
| CN302308291S (zh) | 电源转换器（cd98-d01bx） | |
| CN302279050S (zh) | 电源转换器（cd98-c04） | |
| CN302382680S (zh) | 电源转换器（cd98-e01bx） | |
| CN302279051S (zh) | 电源转换器（cd98-b04） | |
| CN302466831S (zh) | 曳引机（1000kg） | |
| CN302175660S (zh) | 移位机（bnqc-jx52） | |
| CN302466832S (zh) | 曳引机（400kg） | |
| CN301704037S (zh) | 垃圾桶（qdt-18-2） | |
| CN302416426S (zh) | 净水器（ep2231） | |
| JP2016084299A5 (ja) | Ｄ−グルコピラノシルグリセロール組成物 |